BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 11815292)

  • 1. The Role of the Epstein-Barr virus in human disease.
    Murray PG; Young LS
    Front Biosci; 2002 Feb; 7():d519-40. PubMed ID: 11815292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus (EBV) and its associated human cancers--genetics, epigenetics, pathobiology and novel therapeutics.
    Tao Q; Young LS; Woodman CB; Murray PG
    Front Biosci; 2006 Sep; 11():2672-713. PubMed ID: 16720343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human B cells on their route to latent infection--early but transient expression of lytic genes of Epstein-Barr virus.
    Kalla M; Hammerschmidt W
    Eur J Cell Biol; 2012 Jan; 91(1):65-9. PubMed ID: 21450364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-γ-inducible protein 16 (IFI16) is required for the maintenance of Epstein-Barr virus latency.
    Pisano G; Roy A; Ahmed Ansari M; Kumar B; Chikoti L; Chandran B
    Virol J; 2017 Nov; 14(1):221. PubMed ID: 29132393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EBNA-1 sequence variations reflect active EBV replication and disease status or quiescent latency in lymphocytes.
    Wang JT; Sheeng TS; Su IJ; Chen JY; Chen MR
    J Med Virol; 2003 Mar; 69(3):417-25. PubMed ID: 12526054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus (EBV) and lymphomagenesis.
    Cesarman E
    Front Biosci; 2002 Feb; 7():e58-65. PubMed ID: 11815280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virology. Epstein-Barr virus turns 50.
    Lieberman PM
    Science; 2014 Mar; 343(6177):1323-5. PubMed ID: 24653027
    [No Abstract]   [Full Text] [Related]  

  • 8. A review of the cytomorphology of Epstein-Barr virus-associated malignancies.
    Michelow P; Wright C; Pantanowitz L
    Acta Cytol; 2012; 56(1):1-14. PubMed ID: 22236740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epstein-Barr virus].
    Tsurumi T
    Nihon Rinsho; 2003 Mar; 61 Suppl 3():582-6. PubMed ID: 12718032
    [No Abstract]   [Full Text] [Related]  

  • 10. Epstein-Barr virus: the first human tumor virus and its role in cancer.
    Pagano JS
    Proc Assoc Am Physicians; 1999; 111(6):573-80. PubMed ID: 10591086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lytic viral replication as a contributor to the detection of Epstein-Barr virus in breast cancer.
    Huang J; Chen H; Hutt-Fletcher L; Ambinder RF; Hayward SD
    J Virol; 2003 Dec; 77(24):13267-74. PubMed ID: 14645583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EBV-Encoded Latent Genes.
    Kanda T
    Adv Exp Med Biol; 2018; 1045():377-394. PubMed ID: 29896676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral Carcinogenesis Beyond Malignant Transformation: EBV in the Progression of Human Cancers.
    Elgui de Oliveira D; Müller-Coan BG; Pagano JS
    Trends Microbiol; 2016 Aug; 24(8):649-664. PubMed ID: 27068530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Epstein-Barr virus and its association with human cancers.
    Baumforth KR; Young LS; Flavell KJ; Constandinou C; Murray PG
    Mol Pathol; 1999 Dec; 52(6):307-22. PubMed ID: 10748864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus-encoded EBNA1 and ZEBRA: targets for therapeutic strategies against EBV-carrying cancers.
    Daskalogianni C; Pyndiah S; Apcher S; Mazars A; Manoury B; Ammari N; Nylander K; Voisset C; Blondel M; Fåhraeus R
    J Pathol; 2015 Jan; 235(2):334-41. PubMed ID: 25186125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus: 40 years on.
    Young LS; Rickinson AB
    Nat Rev Cancer; 2004 Oct; 4(10):757-68. PubMed ID: 15510157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy for Epstein-Barr virus-associated malignancies.
    Long HM; Parsonage G; Fox CP; Lee SP
    Drug News Perspect; 2010 May; 23(4):221-8. PubMed ID: 20520851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus associated polymorphic lymphoproliferative disorders occurring in nontransplant settings.
    Tao J; Wasik MA
    Lab Invest; 2001 Apr; 81(4):429-37. PubMed ID: 11304562
    [No Abstract]   [Full Text] [Related]  

  • 19. Chromatin Structure of Epstein-Barr Virus Latent Episomes.
    Lieberman PM
    Curr Top Microbiol Immunol; 2015; 390(Pt 1):71-102. PubMed ID: 26424644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic dysregulation of the host cell genome in Epstein-Barr virus-associated neoplasia.
    Niller HH; Wolf H; Minarovits J
    Semin Cancer Biol; 2009 Jun; 19(3):158-64. PubMed ID: 19429479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.